Form 4: Andrea B. Smith Receives HCA Healthcare Equity Award

Director Andrea B. Smith was granted 509 restricted share units as part of HCA Healthcare's annual director equity compensation.

Summary

• Director Andrea B. Smith acquired 509 restricted share units (RSUs) on April 28, 2026.
• The grant represents an annual director equity award.
• The RSUs vest on the earlier of the 2027 annual shareholders' meeting or the first anniversary of the grant date.
• Vested shares will be delivered to the director upon her departure from the Board of Directors.
• Following this transaction, the director holds 4,666 shares directly and 82 shares indirectly through managed accounts.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The RSUs are scheduled to vest in 2027, aligning with the company's standard annual director compensation cycle.

Industry Context

StockSavvy.ai notes that this is a routine disclosure of director compensation, consistent with standard corporate governance practices for large-cap healthcare providers.

Comparison to Industry Standards

• The use of restricted share units for director compensation is a standard practice among S&P 500 companies to ensure board alignment with shareholder interests.

Stakeholder Impact

• Minimal impact; reflects standard director compensation practices.

Next Steps

• Vesting of the 509 restricted share units in 2027.

Key Dates

Keywords

HCA Healthcare, HCA, Director Compensation, Insider Transaction, Restricted Share Units, Corporate Governance